MITOXANTRONE, 5-FU, AND LEUCOVORIN IN BREAST-CANCER

被引：2
|
作者：
SWAIN, SM
HONIG, SF
机构：
[1] Lombardi Cancer Research Center, Department of Medicine, Division of Medical Oncology, Washington, District of Columbia
来源：
MEDICAL AND PEDIATRIC ONCOLOGY | 1994年 / 22卷 / 06期
关键词：
MITOXANTRONE; 5-FLUOROURACIL; LEUCOVORIN; CHEMOTHERAPY OF BREAST CANCER;
D O I：
10.1002/mpo.2950220603
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Eighteen patients (17 evaluable for response) with metastatic breast cancer were treated with mitoxantrone 10 mg/m(2) day 1, followed by 5-fluorouracil 375 mg/m(2) day 1-5, and high-dose leucovorin 500 mg/m(2) day 1-5 given every 28 days. There was one complete and four partial responses for an objective response rate of 30% and 41% stable disease. The major toxicities were hematologic and gastrointestinal. This regimen has activity in metastatic breast cancer comparable to conventional and/or standard chemotherapy regimens for advanced disease. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码：370 / 374
页数：5
相关论文
共 50 条
  • [41] Treatment of non-resectable pancreatic cancer with intraperitoneal 5-FU and leucovorin IV
    Öman, M
    Blind, PJ
    Naredi, P
    Gustavsson, B
    Hafström, LO
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2001, 27 (05): : 477 - 481
  • [42] A phase II randomized study of Combined Infusional Leucovorin Sodium and 5-FU versus the Leucovorin Calcium followed by 5-FU both in combination with Irinotecan or Oxaliplatin in patients with metastatic colorectal cancer
    Bleiberg, H.
    Vandebroek, A.
    Deleu, I.
    Vergauwe, P.
    Kalantari, H. Rezaei
    D'Haens, G.
    Paesmans, M.
    Peeters, M.
    Efira, A.
    Humblet, Y.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2012, 75 (01): : 14 - 21
  • [43] TAMOXIFEN AND CONJUGATED ESTROGENS (PREMARIN) FOLLOWED BY SEQUENCED METHOTREXATE AND 5-FU IN REFRACTORY ADVANCED BREAST-CANCER
    EISENHAUER, EA
    BOWMAN, DM
    PRITCHARD, KI
    PATERSON, AHG
    RAGAZ, J
    PLENDERLEITH, I
    GEGGIE, PHS
    MAXWELL, I
    CANCER TREATMENT REPORTS, 1984, 68 (11): : 1421 - 1422
  • [44] TREATMENT OF PRIMARY BREAST-CANCER WITH L-PAM/5-FU AND TAMOXIFEN - AN INTERIM-REPORT
    FISHER, B
    BREAST CANCER RESEARCH AND TREATMENT, 1983, 3 : S7 - S17
  • [45] SIGNIFICANCE OF RELAPSE FOLLOWING ADJUVANT THERAPY WITH CMF OR 5-FU IN HIGH-RISK BREAST-CANCER
    CHLEBOWSKI, RT
    WEINER, JM
    LUCE, J
    HESTORFF, R
    LANG, JE
    REYNOLDS, R
    GODFREY, T
    RYDEN, VMJ
    BATEMAN, JR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 146 - 146
  • [46] PHASE-II STUDY OF MITOXANTRONE, LEUCOVORIN, AND INFUSIONAL FLUOROURACIL FOR TREATMENT OF METASTATIC BREAST-CANCER
    JONES, SE
    MENNEL, RG
    BROOKS, B
    WESTRICK, MA
    ALLISON, MA
    PAULSON, RS
    TILMANN, K
    REA, B
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (10) : 1736 - 1739
  • [47] Trimetrexate (TMTX) modulation of 5-fluorouracil leucovorin (5-FU/LV) for advanced colorectal cancer
    Blanke, C
    Kasimis, B
    Schein, P
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 748 - 748
  • [48] Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer
    Taïeb, J
    Artru, P
    Baujat, B
    Mabro, M
    Carola, E
    Maindrault, F
    Tournigand, C
    Krulik, M
    Louvet, C
    de Gramont, A
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (05) : 661 - 666
  • [49] MITOXANTRONE, 5-FLUOROURACIL AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER
    MARTONI, A
    RANI, P
    ERCOLINO, L
    CANOVA, N
    PANNUTI, F
    CHEMIOTERAPIA, 1988, 7 (05): : 345 - 349
  • [50] 5-FU for cervical cancer
    不详
    AIDS PATIENT CARE AND STDS, 2000, 14 (03) : 173 - 173
12345